Using cold plasma to improve healing of alcohol-related tissue injuries
Official title: Investigation of cold plasma for healing alcohol-induced tissue injury
Funded at Seton Hall University · NIH-10870602 · Data updated 2026-11-12
This study is looking at how a special cold plasma treatment might help heal wounds better for people who have binge-drunk alcohol, using both rats and human skin samples to see if it can speed up healing and lower the chance of infections.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seton Hall University NIH-funded |
| Lab location | 1 site (South Orange, United States) |
| Project start | September 20, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $76,624 |
| NIH project number | 1R03AA031535-01 |
| Project ID | NIH-10870602 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced tissue injuries related to binge drinking.
✕Less likely to help
Patients who do not have any history of alcohol consumption or related tissue injuries may not benefit from this research.
What this research studies
This research investigates how cold plasma treatment can enhance the healing process of tissues damaged by binge drinking. It focuses on understanding the effects of cold plasma on wound healing phases, particularly in individuals who have consumed alcohol. The study will utilize both a rat model and human skin organoids to assess how cold plasma can improve wound closure and reduce infection risks associated with alcohol consumption. Patients may benefit from insights gained about new treatment options for wounds affected by alcohol.
Why it matters
Potential benefit: If successful, this research could lead to improved healing methods for patients with alcohol-related tissue injuries.
How similar studies have gone: Previous studies have shown promising results with cold plasma in wound healing, indicating potential for success in this novel application.
Where this research is happening
-
Seton Hall University
South Orange, United States Active
Researchers
- Principal investigator: Chang, Sulie L. — Seton Hall University
- Study coordinator: Chang, Sulie L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.